|
|
The First Annual Symposium on Biopharmaceuticals May 19, 2002 |
|
|
The First Annual Symposium on Biopharmaceuticals May 19, 2002 |
|
Home | Program | Awards | Registration | Directions | Sponsors | About SDCA |
| FINAL PROGRAM | |
| Program Chair | Hui Cai, Vice President of Science and Business, San Diego Chinese Association |
|
8:30-9:00
|
Networking |
|
|
|
|
9:00-9:05
|
Conference Opening, Welcome |
| Paul Yang, President, San Diego Chinese Association | |
| Session I | Trends in Drug Discovery |
| Chair | Kevin Liu, Associate Director, Kalypsys |
| 9:05-9:25 | "Using Bioinformatics in Drug Discovery" |
| Jackson Wan, Director, Johnson & Johnson Pharmaceutical Research and Development | |
| 9:25-9:45 | “High Throughput X-Ray Crystallography and Drug Discovery” |
| Charlie Xiao, Director, Syrrx Inc. | |
| 9:45-10:05 | “Supercritical Fluid Chromatography Applications for Combinatorial Chemistry” |
| Bill Farrell, Senior Scientist, Pfizer Global Research and Development | |
| 10:05-10:25 | "Nuclear Receptors and Drug Discovery Opportunities" |
| Lin Zhi, Director, Ligand Pharmaceuticals | |
| 10:25-10:40 | Coffee Break |
| Session II | Technology Platform and Business Models |
| Chair | Suixiong Cai, Senior Director, Maxim Pharmaceuticals |
| 10:40-11:00 |
“TOGA Technology: A Powerful Tool for Transcriptional Profiling” |
| Cathy Chang, Director, Digital Gene Technologies | |
| 11:00-11:20 | “Genome-wide SNP Analysis to Discover Complex Disease Genes” |
| Michael Shi, Senior Director, Sequenom Inc. | |
| 11:20-11:40 | “Genomics Technology and Its Application in Molecular Diagnostics of Cancer” |
| Yixin Wang, Principal Scientist, Johnson & Johnson Pharmaceutical Research and Development | |
| 11:40-12:00 | “GNF, What Are We About” |
| Yun He, Associate Director, Biomedical Research Center, Genomics Institute of the Novartis Research Foundation | |
| 12:00-1:20 | Lunch Break |
| 12:00-1:20 | Round Table Discussions (Concurrent) |
| RT1 | How to Set up a Chemical Company |
| RT2 | Bioinformatics and Drug Discovery |
| RT3 | Diagnostic Reagents and Molecular Devices |
| RT4 | When and How to Protect Intellectual Property |
| RT5 | Securing Financing |
| RT6 | Going IPO! |
| RT7 | BioPharmaceutical Industry in China |
| RT8 | Chinese Government Policies on BioPharmaceutical Joint Venture |
| Host: The Consulate General of the People’s Republic of China in Los Angeles | |
| 12:00-1:20 | Job Fair (Concurrent) |
| 1:20-2:15 | SDCA Awards and Award Lectures |
| Recipient of SDCA Achievement Award | |
| Dr. Xumu Zhang, Founder and CTO of Chiral Quest; Associate Professor of Pennsylvania State University | |
| Winner of the 2002 American Chemical Society Arthur C. Cope Scholar Award. His development of efficient catalysts for asymmetric synthesis of biologically active compounds has been described as having “a similar impact to the research conducted” by 2001 chemistry Nobel Prize winner Ryoji Noyori “in asymmetric hydrogenation of simple ketones”- Chemical &Engineering News | |
| Recipient of SDCA Entrepreneur Award | |
| Dr. Naishu Wang, President of Alfa Scientific Designs Inc. (Alfa) | |
| Named "The 2002 SBA San Diego District Minority Small Businessperson of the Year". Under her entrepreneurial leadership, Alfa has 38 IVD products approved by FDA with 510K clearances for sales in US domestic market and International markets. Alfa has also had 36 IVD products CE mark approved for sales in the 15 member states of Western European Union. | |
| Session III | Bioentrepreneur: Challenges and Opportunities |
| Chair | Chris Bai, Vice President of Production, American Peptide Company |
| 2:15-2:35 | “Initiating a Service Company in Biotech” |
| Jun Wang, President, GenBase | |
| 2:35-2:55 | “Information Systems and Future of Genomic Medicine” |
| David Wang, Executive Vice President, First Genetic Trust, Inc. | |
| 2:55-3:15 | “Bio-entrepreneurial Experience of One Million Flying Miles” |
| Chun Shen, President, Egen Corporation | |
| 3:15-3:30 | Coffee Break |
| Session IV | Setting up Company: All the Nuts and Bolts |
| Chair | Mang Yu, Founder, Perlan Therapeutics / Scientific Co-Founder, Immusol |
| 3:30-4:00 | “Building an Intellectual Property Foundation for Your Company” |
| Vickie Norton, Partner, Brobeck, Phleger & Harrison, LLP | |
| 4:00-4:30 | “Capital Formation Strategies” |
| Dan Dearen, Managing Director, Saints Ventures | |
| 4:30-5:00 | “Growing and Exiting through Mergers & Acquisitions: Critical Issues in Today’s Economy” |
| Eddie Rodriguez, Partner, Brobeck, Phleger & Harrison, LLP | |
| 5:00-5:05 | Closing Remarks |
| Hon. Susan Davis, US Congresswoman |
